Karyopharm Therapeutics (KPTI) Insider Trading & Ownership → Biden out June 13; Kamala won’t replace him? (From Paradigm Press) (Ad) Free KPTI Stock Alerts $1.08 0.00 (0.00%) (As of 05/2/2024 ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Karyopharm Therapeutics (NASDAQ:KPTI) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage4.30%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$50,190.80Number OfInsiders Selling(Last 12 Months)6Amount OfInsider Selling(Last 12 Months)$278,847.52 Get KPTI Insider Trade Alerts Want to know when executives and insiders are buying or selling Karyopharm Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address KPTI Insider Buying and Selling by Quarter Ad AltimetryUrgent Nvidia WarningCould Steve Job's 'Final Prophecy' Make You Rich? Just before he died, Steve Jobs issued a "Final Prophecy" that's now coming true... and making some people rich. In one recent 90-day stretch, 50 companies related to Jobs' "Final Prophecy" soared by 100% or more. What was Steve Jobs' last big prediction, and how can you get in on it? Professor Joel Litman explains everything... including the surprising group of stocks moving higher, and his No. 1 favorite stock in this space.Click here to access… Karyopharm Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails4/22/2024Reshma RangwalaEVPSell6,789$1.17$7,943.13 4/4/2024Richard A PaulsonCEOSell3,563$1.29$4,596.27 3/5/2024Richard A PaulsonCEOSell3,573$1.30$4,644.90 2/29/2024Michael ManoSVPSell16,973$1.17$19,858.41 2/29/2024Michael MasonCFOSell27,687$1.17$32,393.79 2/29/2024Reshma RangwalaEVPSell15,667$1.17$18,330.39 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 2/29/2024Richard A PaulsonCEOSell80,470$1.17$94,149.90 2/27/2024Michael MasonCFOSell2,545$1.32$3,359.40 2/15/2024Stuart PoultonEVPSell5,847$1.33$7,776.51 2/6/2024Michael MasonCFOSell4,205$1.59$6,685.95 2/6/2024Richard A PaulsonCEOSell4,012$1.59$6,379.08 1/4/2024Richard A PaulsonCEOSell4,114$0.82$3,373.48 12/4/2023Richard A PaulsonCEOSell3,622$0.79$2,861.38 11/6/2023Richard A PaulsonCEOSell3,606$0.92$3,317.52 10/4/2023Richard A PaulsonCEOSell3,589$1.27$4,558.03 9/12/2023Garen G BohlinDirectorBuy41,140$1.22$50,190.80 9/1/2023Michael ManoSVPSell3,888$1.33$5,171.04 9/1/2023Michael MasonCFOSell6,913$1.33$9,194.29 9/1/2023Sohanya Roshan ChengEVPSell7,415$1.33$9,861.95 8/7/2023Richard A PaulsonCEOSell3,722$1.72$6,401.84 7/28/2023Stuart PoultonEVPSell2,845$1.70$4,836.50 7/5/2023Richard A PaulsonCEOSell3,538$1.72$6,085.36 6/8/2023Sohanya Roshan ChengEVPSell1,839$2.35$4,321.65 5/4/2023Richard A PaulsonCEOSell3,805$3.35$12,746.75 (Data available from 1/1/2013 forward) KPTI Insider Trading Activity - Frequently Asked Questions Who is on Karyopharm Therapeutics's Insider Roster? The list of insiders at Karyopharm Therapeutics includes Deepika Pakianathan, Garen G Bohlin, Jatin Shah, Michael Kauffman, Michael Mano, Michael Mason, Reshma Rangwala, Richard A Paulson, Sharon Shacham, Sohanya Roshan Cheng, Stephen Mitchener, and Stuart Poulton. Learn more on insiders at KPTI. What percentage of Karyopharm Therapeutics stock is owned by insiders? 4.30% of Karyopharm Therapeutics stock is owned by insiders. Learn more on KPTI's insider holdings. Which Karyopharm Therapeutics insiders have been buying company stock? The following insider purchased KPTI shares in the last 24 months: Garen G Bohlin ($50,190.80). How much insider buying is happening at Karyopharm Therapeutics? Insiders have purchased a total of 41,140 KPTI shares in the last 24 months for a total of $50,190.80 bought. Which Karyopharm Therapeutics insiders have been selling company stock? The following insiders have sold KPTI shares in the last 24 months: Deepika Pakianathan ($2,126,692.50), Michael Mano ($25,029.45), Michael Mason ($89,214.62), Reshma Rangwala ($53,692.02), Richard A Paulson ($395,527.08), Sohanya Roshan Cheng ($56,318.48), Stephen Mitchener ($19,261.71), and Stuart Poulton ($31,335.12). How much insider selling is happening at Karyopharm Therapeutics? Insiders have sold a total of 655,982 Karyopharm Therapeutics shares in the last 24 months for a total of $2,797,070.98 sold. More Insider Trading Tools from MarketBeat Related Companies: Repare Therapeutics Insider Buying Vistagen Therapeutics Insider Buying Annovis Bio Insider Buying Emergent BioSolutions Insider Buying Amylyx Pharmaceuticals Insider Buying GlycoMimetics Insider Buying Relmada Therapeutics Insider Buying PDS Biotechnology Insider Buying Nuvectis Pharma Insider Buying Societal CDMO Insider Buying Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: The 3 Hottest Insiders Buys This Month 3 Companies Buying Back Cheap Stock LatelyPagaya Technologies: An AI Fintech That Insiders Are BuyingThe 5 Stocks Most Sold By Insiders This Year3 Cheap Stocks Insiders are Buying: Investors Should Avoid 1 This page (NASDAQ:KPTI) was last updated on 5/2/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressUrgent Nvidia WarningAltimetryThe A.I. story nobody is telling you (Read ASAP)TradeSmithYour bank is lying to you.MyBankTrackerThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingTrump just won 2024Porter & CompanyHe Is Giving Away BitcoinCrypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Karyopharm Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.